Place of Origin: | CHINA |
---|---|
Brand Name: | TINGYI |
Certification: | GMP , ISO 9001:2008 |
Model Number: | 58186-27-9 |
Minimum Order Quantity: | 10g |
Price: | Contact Us |
Packaging Details: | Stealth And Discreet Packaging |
Delivery Time: | Within 7 Working Days |
Payment Terms: | Bank Transfer - Bitcoin - Western Union - MoneyGram |
Supply Ability: | 100 KG/Month |
Product Name: | Idebenone | Other Name: | Avan;Daruma;Mnesis |
---|---|---|---|
CAS: | 58186-27-9 | MF: | C19H30O5 |
MW: | 338.44 | EINECS: | 1308068-626-2 |
Melting Point: | 52-55°C | ||
High Light: | pharmaceutical anabolic steroids,pharmaceutical fine chemicals |
Idebenone
Basic Information:
Product Name: Idebenone
Synonyms: 2,3-Dimethoxy-6-(10-hydroxydecyl)-5-methyl-1,4-
benzoquinone;Avan;Daruma;Mnesis;IDEBENONE(PATENTED-NOSUPPLY);5,6-Dimethoxy-2-(10-
hydroxydecyl)-3-methyl-1,4-benzoquinone;5,6-dimethoxy-2-(10-hydroxydecyl)-3-methyl-5-
cyclohexadiene-1,4-dione;cv 2619 idebenone
CAS: 58186-27-9
MF: C19H30O5
MW: 338.44
EINECS: 1308068-626-2
Melting point: 52-55°C
Storage temp: Room temp
Appearance: Yellow-Orange Crystalline Solid
Description:
Idebenone is an organic compound belonging to the quinone family, being similar to coenzyme
Q-10. It is a kind of drug developed by Takeda Pharmaceutical Company for the treatment of
Alzheimer’s disease and some other cognitive defects. However, these have been not very
much progress associated with this indication. It is now also used for the treatment of
Friedreich’s ataxia with a positive effect on cardiac hypertrophy and neurological
function. However, this indication is only approved in Canada, not in Europe and US. It is
now under investigation on its efficacy for the treatment of Duchenne muscular dystrophy,
Leber’s hereditary optic neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and
stroke-like episodes) as well as primary progressive multiple sclerosis. The efficacy of
this drug still demands more evidences.
Uses:
1. cognition enhancer, nootropic
2. chemotherapy drug
3. Ubiquinone derivative with protective effects against cerebral ischemia. Nootropic
Definition ChEBI:
A member of the class of 1,4-benzoquinones which is substituted by methoxy groups at
positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at
positions 6. Initially developed for the treatment of Alzheimer's disease, benefits ere
modest; it was subsequently found to be of benefit for the symptomatic treatment of
Friedreich's ataxia.
Biological Activity:
Antioxidant and neuroprotective agent. Protects mitochondrial membranes against lipid
peroxidation and blocks glutamate neurotoxicity in vitro and in vivo . Inhibits apoptosis
of astrocytes via increased NGF production.
Usage:
1. Brain function enhancer, can improve brain energy metabolism, improve brain function, and a mild antihypertensive effect. Clinical for cerebral infarction, cerebral hemorrhage and atherosclerosis sequelae caused by brain dysfunction, low consciousness, mood disorders, language disorders, dementia and other patients.
2. Central nervous system stimulant.
3. Used as a brain circulation to improve drugs, intelligence promotion drugs
Nootropics Drug (Raw Powder) | |
Noopept | Rivastigmine |
Sunifiram | Oxiracetam |
Unifiram | Donepezil |
Coluracetam | Brivaracetam |
Masitinib | Levetiracetam |
Piracetam | Rivastigmine tartrate |
Idebenone | Fladrafinil |
Pramiracetam | PRL-8-53 |
Rivastigmine | Vinpocetine |